Replies to post #765168 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Thanks DD!
Honestly, I was quite surprised myself to get such a clear confirmation about the DCVax-L application. At first, the MHRA board member gave the standard cautious reply, saying he couldn’t be more helpful — which is exactly what you'd expect from a regulator during an ongoing review. But then came that follow-up message, explicitly stating that DCVax-L is being processed as an innovative medicine and is not part of the backlogs or delays. That felt significant.

I don’t think this was random or accidental. With all the recent public attention — parliamentary questions from Sarah Owen, and even MHRA's own public meeting on March 18 where they tried to show they are managing things well — I get the sense they wanted to gently correct any public concerns without breaching confidentiality. No details on the outcome, of course, but just enough to signal that the process is on track and not stuck.

So no, I don’t think this was just chance — more likely, this was a carefully measured reassurance, in line with the current scrutiny MHRA is under. And maybe my email just hit the right note at the right time.

[dennisdave]

This is by far the best news I’ve read in ages.

You could have read that news on the MHRA website already for two weeks now you great researcher you, but ok
https://www.gov.uk/government/publications/mhra-performance-data/mhra-performance-data

"On 31 March 2025, we cleared all backlogs related to licence applications for innovative and established medicines. All new national licence applications submitted after 1 September 2024 continue to be assessed within our target of 210 days, with an average timescale of 160 days in March."

Its wild posters here are hysterically grateful for Lykiri, confirming what is on the MHRA website for two weeks now. Good grief

[exwannabe]

So we now know as a fact that the reason -L has not already been approved is not MHRA being slow (as most all longs were claiming) but either they have majopr objections or NWBO is taking a very long time to address issues. And if the latter, one really must wonder how serious the issues are.,

Would NWBO disclose a CHM letter? Given their past failures on known disclosures, I suspect not.